Physician profile
Carter E Tharpe
NPI 1972547651
$3,967.22
in general payments reported to CMS, 2019-2025
34 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $65.08 · 2021: $336 · 2022: $627 · 2023: $555 · 2024: $378 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $831.98 | 2019-2025 | Watchman Flx, General - Stents, Rotapro |
| Abbott Laboratories | $410.75 | 2021-2025 | Esprit, Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $409.97 | 2019-2024 | |
| Shockwave Medical, INC | $297.09 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $227.63 | 2019-2024 | Opsumit, Uptravi |
| Medtronic Vascular, INC. | $218.12 | 2019 | |
| Cardiovascular Systems INC. | $178.91 | 2021-2022 | |
| Pfizer INC. | $140.49 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $125.88 | 2019-2024 | Xarelto |
| Recor Medical INC | $124.15 | 2025 | Paradise Ultrasound Renal Denervation System |
| Kestra Medical Technology Services, INC. | $122.37 | 2025 | Assure Wcd |
| Amgen INC. | $97.11 | 2019-2025 | Repatha, Repatha |
| Inspire Medical Systems, INC. | $92.76 | 2025 | Inspire |
| Astellas Pharma US INC | $75.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $74.33 | 2019-2023 | Farxiga |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $69.31 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $55.73 | 2021-2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.82 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $49.83 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $33.72 | 2024 | Arcalyst |
| Chiesi USA, INC. | $29.92 | 2019-2025 | Kengreal |
| Edwards Lifesciences Corporation | $27.59 | 2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $27.46 | 2023 | |
| Abiomed | $26.88 | 2024 | Impella |
| Cordis US Corp. | $26.44 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $26.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.96 | 2022 | |
| Gilead Sciences, INC. | $16.22 | 2019 | |
| Novo Nordisk INC | $15.43 | 2023 | Ozempic |
| Alnylam Pharmaceuticals INC. | $14.56 | 2024 | Amvuttra |
| United Therapeutics Corporation | $14.15 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.69 | 2023 | |
| Osprey Medical INC | $11.00 | 2019 | |
| Lundbeck LLC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carter Tharpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.